Cardiff Oncology: Q1 Earnings Snapshot

May 5, 2022 GMT

SAN DIEGO (AP) _ Cardiff Oncology, Inc. (CRDF) on Thursday reported a loss of $11 million in its first quarter.

On a per-share basis, the San Diego-based company said it had a loss of 25 cents.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 23 cents per share.

The molecular diagnostic company posted revenue of $74,000 in the period.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on CRDF at